Hydrochloric Acid → HCID 58089833, 화합물
반응식
[CH:1]12[NH:8][CH:5]([CH2:6][CH2:7]1)[CH2:4][CH:3]([N:9]1[CH2:14][CH2:13][C:12]3([C:23]4[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=4)[CH2:17][N:16]([C:24]([O:26][C:27]([CH3:30])([CH3:29])[CH3:28])=[O:25])[CH2:15]3)[CH2:11][CH2:10]1)[CH2:2]2.[C:31](Cl)(=[O:38])[O:32][C@@H:33]1[CH2:37][CH2:36][O:35][CH2:34]1.C(N(CC)CC)C.Cl>CCOCC>[O:35]1[CH2:36][CH2:37][C@@H:33]([O:32][C:31]([N:8]2[CH:1]3[CH2:7][CH2:6][CH:5]2[CH2:4][CH:3]([N:9]2[CH2:10][CH2:11][C:12]4([C:23]5[C:18](=[CH:19][CH:20]=[CH:21][CH:22]=5)[CH2:17][N:16]([C:24]([O:26][C:27]([CH3:30])([CH3:29])[CH3:28])=[O:25])[CH2:15]4)[CH2:13][CH2:14]2)[CH2:2]3)=[O:38])[CH2:34]1참가 물질
실험 절차
tert-Butyl 1′-(8-azabicyclo[3.2.1]octan-3-yl)-1H-spiro[isoquinoline-4,4′-piperidine]-2(3H)-carboxylate 4c (205 mg, 0.5 mmol) was suspended in Et2O (10 mL) and treated with the (R)-tetrahydrofuran-3-yl carbonochloridate (150 mg, 1 mmol) and triethylamine (0.21 mL, 1.5 mmol, 3 eq). The reaction was stirred at room temperature for 30 min and was then treated with 1N aq. HCl. The phases were separated, the aqueous phase was brought to a basic pH by adding solid KOH, and the resulting suspension was extracted with CH2Cl2 (3×10 mL). The combined organic extracts were dried over Na2SO4 and concentrated to provide crude tert-butyl 1′-(8-(((R)-tetrahydrofuran-3-yloxy)carbonyl)-8-azabicyclo[3.2.1]octan-3-yl)-1H-spiro[isoquinoline-4,4′-piperidine]-2(3H)-carboxylate 4d as a colorless, viscous oil (230 mg, 88% yield). LC/MS m/z [M+H]+ 526.2, retention time 2.54 min (10-99% CH3CN—H2O gradient, with 0.05% TFA, 5 min.
후처리
- customThe phases were separated
- additionby adding solid KOH
- extractionthe resulting suspension was extracted with CH2Cl2 (3×10 mL)
- dry with materialThe combined organic extracts were dried over Na2SO4
- concentrationconcentrated
출처 및 근거
- ORD 기록
- ord-af25793020104a01a738860a0745d16b
- 출처 데이터셋
- uspto-grants-2011_01
- 특허 번호
- US07863449B2
반응 노트
불러오는 중…